MedComm 润色咨询

MedComm

出版年份:暂无数据 年文章数:94 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=472216246, cover=https://img.medsci.cn/2020617/1592353845504_4754896.Jpeg, fullname=MedComm, abbr=MedComm, pyear=暂无数据, frequence=null, articleNumbers=94, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均5.43月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2688-2663, greenSci=https://www.greensci.net/search?kw=2688-2663, scijournal=https://www.scijournal.org/impact-factor-of-MedComm.shtml, medsciHotlightString=null, medsciHotlightRealtime=13.486, medsciHotlight=4.249, medsciHotlight5year=0.707667, citescore=0.0, hIndex=0, impactFactor=9.9, orgnization=wiley, orgnizationUrl=https://onlinelibrary.wiley.com/, country=null, countryCn=null, isOa=1, isOaString=是, sciScie=null, bigclassCas=null, smallclassCas=, website=https://onlinelibrary.wiley.com/journal/26882663, websiteHits=2217, guideForAuthor=https://onlinelibrary.wiley.com/page/journal/26882663/homepage/author-guidelines, guideForAuthorHits=370, submitWebsite=https://mc.manuscriptcentral.com/medcomm, submitWebsiteHits=1120, content=<p style="color: #1c1d1e;"><strong>Aim of the journal</strong></p> <p style="color: #1c1d1e;"><em>MedComm</em> is a peer-reviewed, online open access journal that publishes the pioneer works providing novel insights into all aspects of medicine on the basis of novelty, timeliness and significance to human health. The journal emphasizes original findings that advance the understanding of pathogenesis or improve the diagnosis and treatment of human disease. Interdisciplinary studies utilizing approaches of molecular biology, cell biology, chemistry, pharmacology or material science to address the issues of clinical, basic and translational medicines are particularly encouraged.</p> <p style="color: #1c1d1e;"><strong>Scope and topics (including keywords)</strong></p> <p style="color: #1c1d1e;"><em>MedComm</em> is interested in topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, nanotechnology and artificial intelligence. The journal focuses on clinical and experimental advances on disease characteristics, pathogenic mechanism and medical techniques.</p> <p style="color: #1c1d1e;">Topics of interest include, but are not limited to:</p> <ul style="color: #1c1d1e;"> <li>Epigenetics, genomics, proteomics and metabonomics</li> <li>Non-coding RNA in disease</li> <li>Cell senescence and cell death</li> <li>Cellular signal transduction</li> <li>Gene therapy and gene editing</li> <li>Cancer immunology and immunotherapy</li> <li>Structural biology, chemical genomics and drug discovery</li> <li>High-definition imaging</li> <li>Artificial intelligence in medicine</li> <li>Stem cells and regenerative medicine</li> <li>Nanomedicine and drug delivery system</li> <li>Early disease diagnosis and biomarkers</li> <li>Clinical trials evaluating new treatments for cancer or other diseases</li> </ul>, totalCites=940, brief=MedComm杂志暂不明确行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #0000ff;">蓝</span>, medsciComment=虽然从国际上看,影响力一般。另外,大家关注整体偏低了一些,但是这是中国本土SCI期刊,取得这样成绩也是相当不错的,希望大家多关注支持!, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=472216246'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=6352, tagName=基础研究, createdHits=6), ImpactFactorTagDto(id=1608, tagName=转化医学, createdHits=4), ImpactFactorTagDto(id=3184, tagName=综述, createdHits=3), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=2), ImpactFactorTagDto(id=42953, tagName=肿瘤药理, createdHits=2), ImpactFactorTagDto(id=3225, tagName=表观遗传学, createdHits=2), ImpactFactorTagDto(id=214, tagName=临床医学, createdHits=2), ImpactFactorTagDto(id=41285, tagName=医学综合, createdHits=2), ImpactFactorTagDto(id=461835, tagName=分子诊断学, createdHits=1), ImpactFactorTagDto(id=365, tagName=卒中, createdHits=1), ImpactFactorTagDto(id=51470, tagName=综合期刊, createdHits=1), ImpactFactorTagDto(id=477367, tagName=综合医学, createdHits=1), ImpactFactorTagDto(id=2433, tagName=临床转化, createdHits=1), ImpactFactorTagDto(id=1925, tagName=癌干细胞, createdHits=1), ImpactFactorTagDto(id=230, tagName=遗传学, createdHits=1), ImpactFactorTagDto(id=1559, tagName=肿瘤学, createdHits=1), ImpactFactorTagDto(id=112, tagName=药学, createdHits=1), ImpactFactorTagDto(id=689, tagName=疾病, createdHits=1)], citeScoreList=null, medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.123), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=7.406), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=12.835), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=13.486)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2688-2663[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=MedComm[ta], article_number=85, article_number_cn=72, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
MedComm/MedComm
ISSN
2688-2663
影响指数话题
预警等级
MedSci期刊指数
13.486 (MedSci实时期刊指数) | 0.707667 (5年期刊指数)
CiteScore值
0.0
h-index
0
h5-median
暂无数据
出版社/管理机构
杂志由 wiley 出版或管理
出版国家/地区
暂无数据
出版周期
暂无数据
出版年份
暂无数据
是否OA
被收录情况
暂无数据
JCR分区
暂无数据
中科院分区
大类:
小类: